The Effectiveness of Chinese Medicine Nuan-gong-ye on Primary Dysmenorrhea

Status: Recruiting
Location: See location...
Intervention Type: Other, Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Primary dysmenorrhea is a common under-diagnosed complaint, with a prevalence of about 45-95% in women of childbearing age and about 10-25% in severe cases. Menstrual pain can be classified as primary or secondary. Primary menstrual pain is a crampy pain in the lower abdomen without any pelvic pathology, which usually occurs 6 to 12 months after the first menstruation. Primary menstrual pain is usually most severe on the first day of the menstrual cycle and lasts for 8 to 72 hours. The cause is still unknown, but studies suggest that it may be related to increased prostaglandins, which cause painful contractions of the uterus. The pain is often accompanied by other menstrual discomfort symptoms, including headache, breast tenderness, drowsiness, nausea, vomiting, constipation or diarrhea, and psychological anxiety, depression or irritability. In the case of secondary menstrual pain, there are clear pelvic pathologies, such as endometriosis, uterine fibroids, and pelvic inflammatory disease.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 20
Maximum Age: 40
Healthy Volunteers: t
View:

• 20-40 year-old women

• Regular menstrual cycle of 21-35 days, with menstruation lasting 3-7 days

• Dysmenorrhea started before the age of 20, and have menstrual pain every month

• No organic lesions on ultrasound within one year (either abdomen or vagina)

• VAS score above 4

• Agree to participate in the study and sign the consent form

Locations
Other Locations
Taiwan
China Medical University Hospital
RECRUITING
Taichung
Contact Information
Primary
HSUAN HSUAN WU
whh900710@gmail.com
+886928030693
Time Frame
Start Date: 2024-03-04
Estimated Completion Date: 2026-02-28
Participants
Target number of participants: 82
Treatments
Experimental: Nuan-gong-ye
Placebo_comparator: Placebo
Sponsors
Leads: China Medical University Hospital

This content was sourced from clinicaltrials.gov